Cargando…
Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents
A scaffold-hopping strategy toward Agomelatine based on in silico screening and knowledge analysis was employed to design novel antidepressant agents. A series of 3, 4-dihydroisoquinoline compounds were selected for chemical synthesis and biological assessment. Three compounds (6a-1, 6a-2, 6a-9) dem...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048153/ https://www.ncbi.nlm.nih.gov/pubmed/27698414 http://dx.doi.org/10.1038/srep34711 |
_version_ | 1782457549319045120 |
---|---|
author | Yang, Yang Ang, Wei Long, Haiyue Chang, Ying Li, Zicheng Zhou, Liangxue Yang, Tao Deng, Yong Luo, Youfu |
author_facet | Yang, Yang Ang, Wei Long, Haiyue Chang, Ying Li, Zicheng Zhou, Liangxue Yang, Tao Deng, Yong Luo, Youfu |
author_sort | Yang, Yang |
collection | PubMed |
description | A scaffold-hopping strategy toward Agomelatine based on in silico screening and knowledge analysis was employed to design novel antidepressant agents. A series of 3, 4-dihydroisoquinoline compounds were selected for chemical synthesis and biological assessment. Three compounds (6a-1, 6a-2, 6a-9) demonstrated protective effects on corticosterone-induced lesion of PC12 cells. Compound 6a-1 also displayed low inhibitory effects on the growth of HEK293 and L02 normal cells and it was further evaluated for its potential antidepressant effects in vivo. The forced swim test (FST) results revealed that compound 6a-1 remarkably reduced the immobility time of rats and the open field test (OFT) results indicated a better general locomotor activity of the rats treated with compound 6a-1 than those with Agomelatine or Fluoxetine. Mechanism studies implied that compound 6a-1 can significantly reduce PC12 cell apoptosis by up-regulation of GSH and down-regulation of ROS in corticosterone-induced lesion of PC12 cells. Meanwhile, the down-regulation of calcium ion concentration and up-regulation of BDNF level in PC12 cells may account for the neuroprotective effects. Furthermore, compound 6a-1 can increase cell survival and cell proliferation, promote cell maturation in the rat hippocampus after chronic treatment. The acute toxicity data in vivo indicated compound 6a-1 exhibited less hepatotoxicity than Agomelatine. |
format | Online Article Text |
id | pubmed-5048153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50481532016-10-11 Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents Yang, Yang Ang, Wei Long, Haiyue Chang, Ying Li, Zicheng Zhou, Liangxue Yang, Tao Deng, Yong Luo, Youfu Sci Rep Article A scaffold-hopping strategy toward Agomelatine based on in silico screening and knowledge analysis was employed to design novel antidepressant agents. A series of 3, 4-dihydroisoquinoline compounds were selected for chemical synthesis and biological assessment. Three compounds (6a-1, 6a-2, 6a-9) demonstrated protective effects on corticosterone-induced lesion of PC12 cells. Compound 6a-1 also displayed low inhibitory effects on the growth of HEK293 and L02 normal cells and it was further evaluated for its potential antidepressant effects in vivo. The forced swim test (FST) results revealed that compound 6a-1 remarkably reduced the immobility time of rats and the open field test (OFT) results indicated a better general locomotor activity of the rats treated with compound 6a-1 than those with Agomelatine or Fluoxetine. Mechanism studies implied that compound 6a-1 can significantly reduce PC12 cell apoptosis by up-regulation of GSH and down-regulation of ROS in corticosterone-induced lesion of PC12 cells. Meanwhile, the down-regulation of calcium ion concentration and up-regulation of BDNF level in PC12 cells may account for the neuroprotective effects. Furthermore, compound 6a-1 can increase cell survival and cell proliferation, promote cell maturation in the rat hippocampus after chronic treatment. The acute toxicity data in vivo indicated compound 6a-1 exhibited less hepatotoxicity than Agomelatine. Nature Publishing Group 2016-10-04 /pmc/articles/PMC5048153/ /pubmed/27698414 http://dx.doi.org/10.1038/srep34711 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Yang, Yang Ang, Wei Long, Haiyue Chang, Ying Li, Zicheng Zhou, Liangxue Yang, Tao Deng, Yong Luo, Youfu Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title | Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title_full | Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title_fullStr | Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title_full_unstemmed | Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title_short | Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents |
title_sort | scaffold hopping toward agomelatine: novel 3, 4-dihydroisoquinoline compounds as potential antidepressant agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048153/ https://www.ncbi.nlm.nih.gov/pubmed/27698414 http://dx.doi.org/10.1038/srep34711 |
work_keys_str_mv | AT yangyang scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT angwei scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT longhaiyue scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT changying scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT lizicheng scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT zhouliangxue scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT yangtao scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT dengyong scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents AT luoyoufu scaffoldhoppingtowardagomelatinenovel34dihydroisoquinolinecompoundsaspotentialantidepressantagents |